Routine biochemical and haematological tests, liver function tests, and serum cholesterol and triglyceride concentrations were normal. Serum thyroid stimulating hormone was undetectable (normal 0'05-4-2 mU/l) and free thyroxine was > 100 pmol/l (normal 12-28) indicating hyperthyroidism. Antithyroid antiobodies were not detectable and a radioactive iodine tyroid scan showed an enlarged gland with increased uptake, compatible with multinodular goitre.
Case report A previously well 48 year old woman, with no risk factors for cardiovascular disease, presented to her local hospital with a 2 day history of severe chest pain and increasing dyspnoea, preceded by a 2 month history of exertional angina and palpitation. On direct questioning she gave a history of resting tremor Routine biochemical and haematological tests, liver function tests, and serum cholesterol and triglyceride concentrations were normal. Serum thyroid stimulating hormone was undetectable (normal 0'05-4-2 mU/l) and free thyroxine was > 100 pmol/l (normal 12-28) indicating hyperthyroidism. Antithyroid antiobodies were not detectable and a radioactive iodine tyroid scan showed an enlarged gland with increased uptake, compatible with multinodular goitre.
Treatment with carbimazole, slow-release propranolol (160 mg twice a day), isosorbide mononitrate (60 mg once a day), and aspirin (150 mg once a day) was started. Coronary angiography (figure A) showed a significant narrowing of the left main stem and a 1 cm long, concentric 90% stenosis in the proximal segment of the left anterior descending artery with delayed distal filling. The right coronary artery was normal. After intra-coronary nitrate was given there was partial resolution of the narrowing in the anterior descending artery, but no resolution of the main stem stenosis. Left ventriculography showed antero-apical akinesia.
Coronary angiography was repeated 3 months later, when she was euthyroid (free thyroxine 28 pmol/l, free triiodothyronine 6-9 pmol/l (normal 3-0-9-0) and thyroid stimulating hormone 0 05 mU/l) and symptom free. There was complete resolution of all coronary abnormalities (figure B).
Discussion
Angina occurs in up to 20% of patients with thyrotoxicosis, usually because of coronary atheroma and increased sympathetic activity.'
The cause of ischaemia and infarction in thyrotoxic patients with normal coronary arteries is unclear. It may be due to in situ coronary thrombosis2 or to a direct metabolic effect of thyroid horomone on the myocardium3 or be secondary to supraventricular tachycardia or atrial fibrillation. 4 
